RPO NucleoGenesis (Private limited company)
RPO NucleoGenesis is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0782.980.238. It was founded on 08-03-2022. Its registered office is in Ghent. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2023 report equity of € 20 385 and a profit of € 2 885. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2024 financial year have not been filed, although the legal deadline has passed.
Information last updated on 07-10-2026.
Company information
Key figures of RPO NucleoGenesis
| 2023 | |
|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 2 885 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 20 385 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 107 514 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 8 231 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - |
Financial estimate
- 2 Board links
Similar companies
Other companies in the same activity in Ghent.
| Company | Town |
|---|---|
| -HEEL BELGIUM | 9031 Gent |
| DELAVAL | 9031 Gent |
| VITONA | 9031 Gent |
| FOUND I.T. | 9031 Gent |
Frequently asked questions
Is RPO NucleoGenesis still active? Yes. The Crossroads Bank for Enterprises lists RPO NucleoGenesis as active.
What is the VAT number of RPO NucleoGenesis? The VAT number of RPO NucleoGenesis is BE 0782.980.238.
When was RPO NucleoGenesis founded? RPO NucleoGenesis was founded on 08-03-2022.
What is the address of RPO NucleoGenesis? The current registered office of RPO NucleoGenesis is Bassebeekstraat 39, 9031 Gand.
When did RPO NucleoGenesis last file annual accounts? The latest annual accounts of RPO NucleoGenesis were filed on 15-07-2024.
Does RPO NucleoGenesis file its annual accounts on time? The annual accounts of RPO NucleoGenesis for the 2024 financial year have not been filed, although the legal deadline has passed.
Is RPO NucleoGenesis financially healthy? Addrly gives RPO NucleoGenesis a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is RPO NucleoGenesis profitable? The annual accounts of RPO NucleoGenesis for 2023 show a profit of € 2 885.
What is the equity of RPO NucleoGenesis? The equity of RPO NucleoGenesis was € 20 385 at the close of the 2023 financial year.
Who are the directors of RPO NucleoGenesis? The annual accounts of RPO NucleoGenesis record 4 mandates. The names, roles and dates are visible with a free account.
Can RPO NucleoGenesis receive Peppol e-invoices? Yes. RPO NucleoGenesis is registered on the Peppol network and can receive structured electronic invoices.
What does RPO NucleoGenesis do? The main activity of RPO NucleoGenesis is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.